Variant report
Variant | nsv983952 |
---|---|
Chromosome Location | chr14:40452126-40481476 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:40457857..40458829-chr14:40749466..40750494,4 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190740064 | chr14:40453402-40453403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545773083 | chr14:40453416-40453417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559405277 | chr14:40453431-40453432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527958937 | chr14:40453434-40453435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs79267576 | chr14:40453472-40453473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561468379 | chr14:40453510-40453511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139562280 | chr14:40453513-40453514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530315360 | chr14:40453520-40453521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528637913 | chr14:40453540-40453541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546636599 | chr14:40453544-40453545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73282949 | chr14:40453547-40453548 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs555119046 | chr14:40453556-40453557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529144994 | chr14:40453578-40453579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142206363 | chr14:40453581-40453582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146758816 | chr14:40453585-40453586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539226284 | chr14:40453592-40453593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182216284 | chr14:40453664-40453665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184964854 | chr14:40453674-40453675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534731914 | chr14:40453688-40453689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs365586 | chr14:40453714-40453715 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs112244864 | chr14:40453739-40453740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537201728 | chr14:40453753-40453754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533897043 | chr14:40453756-40453757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556886205 | chr14:40453757-40453758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576976458 | chr14:40453758-40453759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539559085 | chr14:40453781-40453782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553130345 | chr14:40453797-40453798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572858499 | chr14:40453799-40453800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35058162 | chr14:40453800-40453801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565839162 | chr14:40459612-40459613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534777092 | chr14:40459690-40459691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554484145 | chr14:40459694-40459695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574448126 | chr14:40459713-40459714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138534387 | chr14:40459783-40459784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557126488 | chr14:40459792-40459793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576897686 | chr14:40459799-40459800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545858403 | chr14:40459801-40459802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs199534714 | chr14:40459872-40459873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190337648 | chr14:40459892-40459893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144135432 | chr14:40459895-40459896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558471976 | chr14:40459915-40459916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561303838 | chr14:40459953-40459954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539420445 | chr14:40460087-40460088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530267141 | chr14:40460105-40460106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549855953 | chr14:40460106-40460107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563490859 | chr14:40460125-40460126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532329879 | chr14:40460162-40460163 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569432894 | chr14:40460198-40460199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs438079 | chr14:40460206-40460207 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs5808058 | chr14:40460209-40460210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 21298110 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Thyroid cancer | 19470727 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:40453400-40453800 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr14:40459600-40460600 | Enhancers | Fetal Kidney | kidney |
3 | chr14:40460600-40460800 | Weak transcription | Fetal Kidney | kidney |
4 | chr14:40460800-40461000 | Enhancers | Fetal Kidney | kidney |
5 | chr14:40463400-40466800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr14:40464800-40467800 | Weak transcription | Pancreas | Pancrea |
7 | chr14:40465000-40466000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr14:40466800-40470600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr14:40470600-40470800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr14:40470800-40471200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr14:40471200-40471800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr14:40471800-40478400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr14:40473400-40474600 | Enhancers | Fetal Kidney | kidney |
14 | chr14:40478400-40479600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr14:40479600-40480800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr14:40480800-40481600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |